XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ DEFICIT (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

       Weighted
Average
   Weighted
Average
 
   Number   Exercise Price   Remaining Life 
Stock Options               
Outstanding December 31, 2022   1,357,466   $7.39    5.41 
Granted   -   $-    - 
Expired   -   $-    - 
Exercised   -   $-    - 
Outstanding March 31, 2023   1,357,466   $7.39    5.07 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of March 31, 2023, and changes during the three months ended March 31, 2023, is presented below:

Nonvested Options  Options   Weighted-Average
Exercise Price
 
Nonvested at December 31, 2022   118,187   $13.07 
Granted   -   $             - 
Vested   25,594   $10.11 
Forfeited   -   $- 
Nonvested at March 31, 2023   92,593   $13.89 
SUMMARY OF WARRANT

A summary of warrant issuances are as follows:

       Weighted
Average
   Weighted
Average
 
   Number   Exercise Price   Remaining Life 
Warrants               
                
Outstanding December 31, 2022   1,537,158   $13.49    2.15 
Granted   -    -    - 
Expired   (482,092)   4.00    - 
Exercised   -    -    - 
Outstanding March 31, 2023   1,055,066   $17.82    2.81